Skip to main content
. 2019 Oct 2;39(40):7872–7881. doi: 10.1523/JNEUROSCI.1106-19.2019

Table 1.

Spinal cord injury participantsa

Participant Age (yr) Gender AIS Level Etiology Time after injury (yr) MAS score Medication(s)
1 61 M D C4 T 13.9 0 None
2 69 M D T4 NT 7.0 0 None
3 66 M C C5 T 17.0 0 None
4 58 F C C4 T 6.0 0 None
5 69 F C L3 T 2.5 0 None
6 28 F C C5 T 2.2 0 GBP
7 70 M C T11 T 3.4 1 BAC
8 68 M D C3 T 11.0 1 GBP, TIZ
9 53 M D L2 T 31.9 1 BAC
10 61 M D C4 NT 4.1 1 GBP
11 41 F C C1 NT 25.0 2 BAC, GBP
12 39 M C C5 T 12.1 2 None
13 70 M C C3 T 7.6 2 BAC
14 21 F C C4 T 1.9 2 None
15 34 M D C2 T 10.3 3 None
16 61 M C T5 NT 41.0 3 None
17 37 M C C5 T 2.2 3 BAC
18 42 M C T2 T 2.1 3 BAC
19 67 M C C7 T 3.0 3 None
20 41 M C C5 T 16.0 3 None
21 44 M C C4 T 10.3 3 None
22 71 M C T7 NT 9.0 3 None
23 19 F C T6 T 6.0 4 BAC
24 61 M D C5 T 16.0 4 None
25 59 M C C5 T 14.3 4 BAC
26 69 M D C4 T 46.0 4 BAC
27 34 M C T12 T 2.3 4 BAC
28 52 M C T5 T 1.8 4 BAC
29 43 M C C4 T 12.1 4 BAC
30 39 M C T10 T 1.6 4 BAC

aT, traumatic; NT, non-traumatic; BAC, baclofen; GBP, gabapentin; TIZ, tizanidine.